Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PARKINSONS DISEASE DRUG INDUSTRY
2.1 Summary about Parkinsons Disease Drug Industry
2.2 Parkinsons Disease Drug Market Trends
2.2.1 Parkinsons Disease Drug Production & Consumption Trends
2.2.2 Parkinsons Disease Drug Demand Structure Trends
2.3 Parkinsons Disease Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Sinemet-CR
4.2.2 Trastal
4.2.3 Madopar
4.2.4 COMT Inhibitor
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Under 40 Years Old
4.3.2 40-65 Years Old
4.3.3 Above 65 Years Old
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Sinemet-CR
5.2.2 Trastal
5.2.3 Madopar
5.2.4 COMT Inhibitor
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Under 40 Years Old
5.3.2 40-65 Years Old
5.3.3 Above 65 Years Old
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Sinemet-CR
6.2.2 Trastal
6.2.3 Madopar
6.2.4 COMT Inhibitor
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Under 40 Years Old
6.3.2 40-65 Years Old
6.3.3 Above 65 Years Old
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Sinemet-CR
7.2.2 Trastal
7.2.3 Madopar
7.2.4 COMT Inhibitor
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Under 40 Years Old
7.3.2 40-65 Years Old
7.3.3 Above 65 Years Old
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Sinemet-CR
8.2.2 Trastal
8.2.3 Madopar
8.2.4 COMT Inhibitor
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Under 40 Years Old
8.3.2 40-65 Years Old
8.3.3 Above 65 Years Old
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Sinemet-CR
9.2.2 Trastal
9.2.3 Madopar
9.2.4 COMT Inhibitor
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Under 40 Years Old
9.3.2 40-65 Years Old
9.3.3 Above 65 Years Old
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 Akorn
10.1.3 GSK
10.1.4 Novartis
10.1.5 Boehringer Ingelheim
10.1.6 Teva Pharmaceutical
10.1.7 Abbvie
10.1.8 Kyowa Hakko Kirin Pharma
10.1.9 Astellas Pharma
10.1.10 Desitin Arzneimittel
10.1.11 Endo Pharmaceuticals
10.1.12 F.Hoffmann-La Roche
10.1.13 H.Lundbeck
10.1.14 Valeant
10.1.15 Apokyn
10.1.16 Orion
10.1.17 Stada Arzneimittel
10.1.18 US WorldMeds
10.1.19 Valeant Pharmaceuticals
10.2 Parkinsons Disease Drug Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 Akorn
10.2.3 GSK
10.2.4 Novartis
10.2.5 Boehringer Ingelheim
10.2.6 Teva Pharmaceutical
10.2.7 Abbvie
10.2.8 Kyowa Hakko Kirin Pharma
10.2.9 Astellas Pharma
10.2.10 Desitin Arzneimittel
10.2.11 Endo Pharmaceuticals
10.2.12 F.Hoffmann-La Roche
10.2.13 H.Lundbeck
10.2.14 Valeant
10.2.15 Apokyn
10.2.16 Orion
10.2.17 Stada Arzneimittel
10.2.18 US WorldMeds
10.2.19 Valeant Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
